☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Roche
Roche’s Tecentriq Hybreza Receives the US FDA’s Approval for Cancer Treatment
September 13, 2024
Roche Reports the P-II (FENopta) Study Data of Fenebrutinib for Treating Relapsing Multiple Sclerosis (RMS)
September 4, 2024
Roche’s PiaSky Receives the EC’s Approval to Treat Paroxysmal Nocturnal Haemoglobinuria (PNH)
August 27, 2024
Roche’s Vabysmo (Faricimab) Receives the EC’s Approval to Treat Retinal Vein Occlusion (RVO)
July 30, 2024
Roche Reports the P-III (RHONE-X) Study Data of Vabysmo for the Treatment of Diabetic Macular Edema (DME)
July 18, 2024
Roche Reports the P-I (CT-996-201) Study Data of CT-996 for Treating Obesity
July 17, 2024
Load more...
Back to Home